Annual Interest Expense
$73.00 M
+$13.60 M+22.90%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual interest expense is currently $73.00 million, with the most recent change of +$13.60 million (+22.90%) on 31 December 2023. During the last 3 years, it has risen by +$16.10 million (+28.30%). REGN annual interest expense is now at all-time high.REGN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$13.80 M
-$1.00 M-6.76%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly interest expense is currently $13.80 million, with the most recent change of -$1.00 million (-6.76%) on 30 September 2024. Over the past year, it has dropped by -$4.00 million (-22.47%). REGN quarterly interest expense is now -47.53% below its all-time high of $26.30 million, reached on 30 September 2020.REGN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$63.00 M
-$4.00 M-5.97%
30 September 2024
Summary:
Regeneron Pharmaceuticals TTM interest expense is currently $63.00 million, with the most recent change of -$4.00 million (-5.97%) on 30 September 2024. Over the past year, it has dropped by -$9.10 million (-12.62%). REGN TTM interest expense is now -13.70% below its all-time high of $73.00 million, reached on 31 December 2023.REGN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.9% | -22.5% | -12.6% |
| 3 y3 years | +28.3% | -2.8% | +8.6% |
| 5 y5 years | +158.9% | +76.9% | +103.9% |
REGN Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +28.3% | -27.0% | +5.3% | -13.7% | +14.6% |
| 5 y | 5 years | at high | +158.9% | -47.5% | +126.2% | -13.7% | +120.3% |
| alltime | all time | at high | +3023.7% | -47.5% | +208.2% | -13.7% | +852.6% |
Regeneron Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.80 M(-6.8%) | $63.00 M(-6.0%) |
| June 2024 | - | $14.80 M(-8.1%) | $67.00 M(-5.8%) |
| Mar 2024 | - | $16.10 M(-12.0%) | $71.10 M(-2.6%) |
| Dec 2023 | $73.00 M(+22.9%) | $18.30 M(+2.8%) | $73.00 M(+1.2%) |
| Sept 2023 | - | $17.80 M(-5.8%) | $72.10 M(+3.6%) |
| June 2023 | - | $18.90 M(+5.0%) | $69.60 M(+9.1%) |
| Mar 2023 | - | $18.00 M(+3.4%) | $63.80 M(+7.4%) |
| Dec 2022 | $59.40 M(+3.7%) | $17.40 M(+13.7%) | $59.40 M(+5.9%) |
| Sept 2022 | - | $15.30 M(+16.8%) | $56.10 M(+2.0%) |
| June 2022 | - | $13.10 M(-3.7%) | $55.00 M(-2.3%) |
| Mar 2022 | - | $13.60 M(-3.5%) | $56.30 M(-1.7%) |
| Dec 2021 | $57.30 M(+0.7%) | $14.10 M(-0.7%) | $57.30 M(-1.2%) |
| Sept 2021 | - | $14.20 M(-1.4%) | $58.00 M(-17.3%) |
| June 2021 | - | $14.40 M(-1.4%) | $70.10 M(+7.2%) |
| Mar 2021 | - | $14.60 M(-1.4%) | $65.40 M(+14.9%) |
| Dec 2020 | $56.90 M(+88.4%) | $14.80 M(-43.7%) | $56.90 M(+16.6%) |
| Sept 2020 | - | $26.30 M(+171.1%) | $48.80 M(+61.1%) |
| June 2020 | - | $9.70 M(+59.0%) | $30.30 M(+5.9%) |
| Mar 2020 | - | $6.10 M(-9.0%) | $28.60 M(-5.3%) |
| Dec 2019 | $30.20 M(+7.1%) | $6.70 M(-14.1%) | $30.20 M(-2.3%) |
| Sept 2019 | - | $7.80 M(-2.5%) | $30.90 M(+1.3%) |
| June 2019 | - | $8.00 M(+3.9%) | $30.50 M(+3.7%) |
| Mar 2019 | - | $7.70 M(+4.1%) | $29.40 M(+4.6%) |
| Dec 2018 | $28.20 M(+12.4%) | $7.40 M(0.0%) | $28.10 M(+5.2%) |
| Sept 2018 | - | $7.40 M(+7.2%) | $26.72 M(+4.8%) |
| June 2018 | - | $6.90 M(+7.8%) | $25.50 M(+6.2%) |
| Mar 2018 | - | $6.40 M(+6.4%) | $24.00 M(-4.4%) |
| Dec 2017 | $25.10 M(+248.6%) | $6.02 M(-2.7%) | $25.10 M(+14.6%) |
| Sept 2017 | - | $6.18 M(+14.5%) | $21.90 M(+35.1%) |
| June 2017 | - | $5.40 M(-28.0%) | $16.21 M(+34.4%) |
| Mar 2017 | - | $7.50 M(+166.7%) | $12.06 M(+67.5%) |
| Dec 2016 | $7.20 M | $2.81 M(+467.1%) | $7.20 M(-186.0%) |
| Sept 2016 | - | $496.00 K(-60.4%) | -$8.37 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $1.25 M(-52.6%) | -$7.59 M(-178.5%) |
| Mar 2016 | - | $2.64 M(-120.7%) | $9.67 M(-32.1%) |
| Dec 2015 | $14.24 M(-61.9%) | -$12.76 M(-1102.2%) | $14.24 M(-57.3%) |
| Sept 2015 | - | $1.27 M(-93.1%) | $33.35 M(-19.3%) |
| June 2015 | - | $18.52 M(+156.8%) | $41.31 M(+25.3%) |
| Mar 2015 | - | $7.21 M(+13.5%) | $32.97 M(-11.8%) |
| Dec 2014 | $37.37 M(-19.5%) | $6.35 M(-31.2%) | $37.37 M(-12.4%) |
| Sept 2014 | - | $9.23 M(-9.3%) | $42.68 M(-5.5%) |
| June 2014 | - | $10.18 M(-12.4%) | $45.19 M(-2.6%) |
| Mar 2014 | - | $11.61 M(-0.4%) | $46.38 M(-0.1%) |
| Dec 2013 | $46.44 M(+2.5%) | $11.66 M(-0.6%) | $46.44 M(+0.4%) |
| Sept 2013 | - | $11.74 M(+3.3%) | $46.27 M(+0.7%) |
| June 2013 | - | $11.37 M(-2.7%) | $45.95 M(+0.3%) |
| Mar 2013 | - | $11.68 M(+1.6%) | $45.82 M(+1.1%) |
| Dec 2012 | $45.30 M(+112.9%) | $11.49 M(+0.7%) | $45.30 M(+4.7%) |
| Sept 2012 | - | $11.41 M(+1.6%) | $43.26 M(+20.5%) |
| June 2012 | - | $11.24 M(+0.7%) | $35.91 M(+25.0%) |
| Mar 2012 | - | $11.16 M(+18.0%) | $28.72 M(+35.0%) |
| Dec 2011 | $21.28 M(+133.4%) | $9.46 M(+132.8%) | $21.28 M(+49.0%) |
| Sept 2011 | - | $4.06 M(+0.3%) | $14.29 M(+14.7%) |
| June 2011 | - | $4.05 M(+8.8%) | $12.46 M(+15.9%) |
| Mar 2011 | - | $3.72 M(+51.3%) | $10.75 M(+17.9%) |
| Dec 2010 | $9.12 M(+290.2%) | $2.46 M(+10.0%) | $9.12 M(+8.3%) |
| Sept 2010 | - | $2.23 M(-4.6%) | $8.42 M(+24.4%) |
| June 2010 | - | $2.34 M(+12.4%) | $6.76 M(+53.0%) |
| Mar 2010 | - | $2.08 M(+18.7%) | $4.42 M(+89.2%) |
| Dec 2009 | $2.34 M(-69.9%) | $1.76 M(+202.2%) | $2.34 M(+302.2%) |
| Sept 2009 | - | $581.00 K(>+9900.0%) | $581.00 K(>+9900.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2009 | - | $0.00(-100.0%) | $2.67 M(-53.0%) |
| Dec 2008 | $7.75 M(-35.6%) | - | - |
| June 2008 | - | $2.67 M(-11.2%) | $5.68 M(+88.8%) |
| Mar 2008 | - | $3.01 M | $3.01 M |
| Dec 2007 | $12.04 M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual interest expense year-on-year change?
- What is Regeneron Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly interest expense year-on-year change?
- What is Regeneron Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM interest expense year-on-year change?
What is Regeneron Pharmaceuticals annual interest expense?
The current annual interest expense of REGN is $73.00 M
What is the all time high annual interest expense for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual interest expense is $73.00 M
What is Regeneron Pharmaceuticals annual interest expense year-on-year change?
Over the past year, REGN annual interest expense has changed by +$13.60 M (+22.90%)
What is Regeneron Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of REGN is $13.80 M
What is the all time high quarterly interest expense for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly interest expense is $26.30 M
What is Regeneron Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, REGN quarterly interest expense has changed by -$4.00 M (-22.47%)
What is Regeneron Pharmaceuticals TTM interest expense?
The current TTM interest expense of REGN is $63.00 M
What is the all time high TTM interest expense for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM interest expense is $73.00 M
What is Regeneron Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, REGN TTM interest expense has changed by -$9.10 M (-12.62%)